CMS modified NCD 108 for 24-hour ambulatory esophageal pH monitoring, effective March 7, 2026. Here's what billing teams need to know.
The Centers for Medicare & Medicaid Services updated its coverage policy for 24-hour ambulatory esophageal pH monitoring under National Coverage Determination NCD 108. This policy governs Medicare reimbursement for the procedure that places an indwelling electrode into the lower esophagus to detect gastric reflux and measure abnormal esophageal acid exposure. The policy document does not list specific CPT or HCPCS codes, so your billing team will need to cross-reference current claims processing instructions to confirm which codes apply to your claims.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | CMS (Centers for Medicare & Medicaid Services) |
| Policy | 24-Hour Ambulatory Esophageal pH Monitoring |
| Policy Code | NCD 108 |
| Change Type | Modified |
| Effective Date | March 7, 2026 |
| Impact Level | Medium |
| Specialties Affected | Gastroenterology, General Surgery, Internal Medicine, ENT |
| Key Action | Audit your documentation to confirm patients meet the two-pathway medical necessity criteria before billing |
CMS 24-Hour Ambulatory Esophageal pH Monitoring Coverage Criteria and Medical Necessity Requirements 2026
The CMS esophageal pH monitoring coverage policy is narrower than many billing teams expect. Medicare does not cover this procedure for every patient with heartburn complaints. Coverage requires the patient to meet one of two specific conditions—and your documentation needs to make that crystal clear before the claim goes out.
Here are the two covered pathways under NCD 108 Medicare criteria:
Pathway 1: The patient is suspected of having gastric reflux, and the patient presents diagnostic problems associated with atypical symptoms.
Pathway 2: The patient's symptoms are suggestive of reflux, but conventional tests have not confirmed the presence of reflux.
That second pathway is where most billing teams trip up. "Conventional tests have not confirmed" is not the same as "we didn't try conventional tests." Your medical record needs to show that prior testing was done and failed to confirm reflux. If the physician skipped straight to pH monitoring without documenting why, you have a medical necessity problem and a likely claim denial waiting to happen.
This is a coverage policy built around diagnostic logic. The procedure is only justified when the simpler path didn't work or can't work. If your gastroenterologists are ordering 24-hour pH monitoring as a first-line diagnostic tool, your documentation is probably not supporting the claim the way Medicare expects.
Prior authorization is not explicitly required under this NCD, but that does not mean you're clear. Your Medicare Administrative Contractor may have a local coverage determination that layers additional requirements on top of the NCD. Check with your MAC before assuming the NCD alone governs your claims. This is especially true if you're seeing denials that don't match the NCD criteria—your MAC may have tightened the rules locally.
Coverage Indications at a Glance
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Suspected gastric reflux with atypical symptoms causing diagnostic difficulty | Covered | Not specified in policy document | Document the atypical presentation clearly in the medical record |
| Symptoms suggestive of reflux, but conventional testing has not confirmed reflux | Covered | Not specified in policy document | Document prior conventional testing and its results (or why it was inadequate) |
| Routine or first-line diagnostic workup for typical reflux symptoms | Not Covered | Not specified in policy document | NCD 108 does not support coverage without meeting one of the two stated criteria |
CMS Esophageal pH Monitoring Billing Guidelines and Action Items 2026
The effective date of March 7, 2026 is already in the rearview mirror. If your team has not reviewed workflows against the updated NCD 108 language, do that now.
| # | Action Item |
|---|---|
| 1 | Audit your documentation templates. Pull a sample of recent 24-hour ambulatory esophageal pH monitoring claims. Check each one for explicit documentation of either atypical symptoms causing diagnostic difficulty, or prior conventional testing that failed to confirm reflux. If your templates don't prompt physicians to document these criteria, update them before your next claim goes out. |
| 2 | Cross-reference with your MAC's LCD. The NCD 108 CMS policy sets the floor, not the ceiling. Your Medicare Administrative Contractor can publish a local coverage determination that adds criteria or narrows indications further. Pull your MAC's LCD for esophageal pH monitoring and compare it line by line against NCD 108. |
| 3 | Confirm the current billing codes with your MAC or claims processing instructions. This policy document does not list specific CPT or HCPCS codes. That is unusual, and it creates real risk. Do not assume you're billing the right code without confirming against current CMS claims processing instructions. A single wrong code on a covered procedure creates a denial that could have been avoided. |
| 4 | Train your physicians on the two-pathway rule. This is not a policy you can fix at the coding desk. The documentation has to come from the physician. Hold a brief review with your gastroenterology and ENT providers before any new orders go out. Explain the two criteria, and explain that "patient has reflux symptoms" alone does not get the claim paid. |
| 5 | Set up a denial tracking filter for esophageal pH monitoring claims. If you're getting denials on this procedure, you need to know the reason codes quickly. A pattern of "medical necessity not established" denials tells you the documentation problem is upstream. A pattern of "non-covered service" denials suggests a coding or eligibility issue. Track them separately. |
| 6 | Loop in your compliance officer if you're unsure how this applies to your patient mix. If your practice sees a high volume of reflux-related workup cases, or if you've had prior audits in this area, get your compliance officer involved before the effective date's impact on pending claims compounds. The two-pathway structure creates real audit exposure if documentation is inconsistent. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for 24-Hour Ambulatory Esophageal pH Monitoring Under NCD 108
Covered CPT Codes (When Selection Criteria Are Met)
The NCD 108 policy document does not specify CPT or HCPCS codes. This is a known gap in the published policy. Your billing team must confirm applicable codes through CMS claims processing instructions or your MAC's published guidance.
| Code | Type | Description |
|---|---|---|
| Not listed in policy | — | Refer to CMS Claims Processing Instructions and MAC LCD for applicable CPT/HCPCS codes |
A Note on Code Identification
The absence of specific codes in the NCD is not a reason to delay billing — it's a reason to verify. Esophageal pH monitoring procedures are typically captured under CPT codes for esophageal function studies, but the NCD 108 document itself does not enumerate them. Billing the wrong code, even for a covered procedure, routes your claim to rejection before medical necessity is even evaluated.
Contact your MAC's provider education line or check the CMS Claims Processing Manual, Chapter 32, to confirm the current code set. Do this before the volume of affected claims grows.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.